NCT00004287View on ClinicalTrials.gov

Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 30, 1995

Conditions

Cystic Fibrosis

Interventions

GENETIC

H5.001CBCFTR

All Listed Sponsors

collaborator

University of Pennsylvania

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004287 - Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter